Usefulness of Left Ventricular Assist Device in the Recovery of Severe Amphetamine-Associated Dilated Cardiomyopathy

Can J Cardiol. 2020 Feb;36(2):317.e5-317.e7. doi: 10.1016/j.cjca.2019.09.024. Epub 2019 Oct 12.

Abstract

Exposure to synthetic drugs such as amphetamines may lead to significant consequences on the cardiovascular system. The prognosis of young adults with amphetamine-induced cardiomyopathy remains poor. We present 2 young patients (aged <40 years) who developed severe dilated cardiomyopathy after chronic amphetamine use. Thorough psychological evaluations demonstrated favorable features with patients being reliable and committed to their health problems. A left ventricular assist device (HeartMate II; Abbott, Chicago, IL) was implanted in the patients shortly after admission to optimize hemodynamic support and evaluate the potential for recovery. Within less than 1 year, significant improvement was achieved and successful explantation of left ventricular assist device was performed in both patients.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphetamine / adverse effects*
  • Cardiomyopathy, Dilated / chemically induced*
  • Cardiomyopathy, Dilated / therapy*
  • Central Nervous System Stimulants / adverse effects*
  • Heart-Assist Devices*
  • Humans
  • Male
  • Severity of Illness Index
  • Substance-Related Disorders / complications*
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • Amphetamine